RTI Surgical, Inc. (RTIX) Rating Lowered to Buy at BidaskClub
BidaskClub downgraded shares of RTI Surgical, Inc. (NASDAQ:RTIX) from a strong-buy rating to a buy rating in a report released on Tuesday.
A number of other equities analysts have also weighed in on the company. Zacks Investment Research lowered RTI Surgical from a hold rating to a sell rating in a research note on Wednesday, May 3rd. TheStreet upgraded RTI Surgical from a d+ rating to a c- rating in a research note on Friday, May 5th. Finally, ValuEngine upgraded RTI Surgical from a sell rating to a hold rating in a research note on Friday, June 2nd.
RTI Surgical (NASDAQ RTIX) traded up 1.82% during mid-day trading on Tuesday, reaching $5.60. The company had a trading volume of 210,769 shares. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $6.00. The stock has a 50 day moving average price of $5.57 and a 200-day moving average price of $4.35. The stock’s market capitalization is $325.51 million.
RTI Surgical (NASDAQ:RTIX) last released its quarterly earnings data on Thursday, April 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $69.90 million for the quarter, compared to the consensus estimate of $67.68 million. RTI Surgical had a negative net margin of 6.85% and a positive return on equity of 1.34%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.03 earnings per share. Equities analysts anticipate that RTI Surgical will post $0.08 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “RTI Surgical, Inc. (RTIX) Rating Lowered to Buy at BidaskClub” was reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.watchlistnews.com/rti-surgical-inc-rtix-rating-lowered-to-buy-at-bidaskclub/1461718.html.
In other RTI Surgical news, EVP Kevin D. Brandt bought 33,130 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were acquired at an average cost of $4.52 per share, for a total transaction of $149,747.60. Following the purchase, the executive vice president now directly owns 126,215 shares of the company’s stock, valued at $570,491.80. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Nicholas J. Valeriani bought 5,500 shares of the firm’s stock in a transaction on Thursday, May 4th. The stock was acquired at an average price of $4.60 per share, for a total transaction of $25,300.00. Following the completion of the purchase, the director now directly owns 25,770 shares in the company, valued at $118,542. The disclosure for this purchase can be found here. Insiders acquired a total of 112,023 shares of company stock worth $514,421 over the last 90 days. Corporate insiders own 4.90% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the company. Kennedy Capital Management Inc. raised its position in shares of RTI Surgical by 20.0% in the first quarter. Kennedy Capital Management Inc. now owns 1,422,371 shares of the medical equipment provider’s stock worth $5,689,000 after buying an additional 236,923 shares in the last quarter. Paradigm Capital Management Inc. NY raised its position in shares of RTI Surgical by 3.7% in the first quarter. Paradigm Capital Management Inc. NY now owns 5,833,270 shares of the medical equipment provider’s stock worth $23,333,000 after buying an additional 208,200 shares in the last quarter. Renaissance Technologies LLC raised its position in shares of RTI Surgical by 28.9% in the fourth quarter. Renaissance Technologies LLC now owns 674,200 shares of the medical equipment provider’s stock worth $2,191,000 after buying an additional 151,200 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of RTI Surgical by 2.0% in the first quarter. Dimensional Fund Advisors LP now owns 3,900,031 shares of the medical equipment provider’s stock worth $15,600,000 after buying an additional 74,933 shares in the last quarter. Finally, IFP Advisors Inc raised its position in shares of RTI Surgical by 69.8% in the first quarter. IFP Advisors Inc now owns 146,000 shares of the medical equipment provider’s stock worth $584,000 after buying an additional 60,000 shares in the last quarter. Institutional investors and hedge funds own 68.74% of the company’s stock.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.